Interview Spotlight: Building Pharmaceutical Anti-Counterfeiting Programs
Dr. Frances Richmond from the University of Southern California (USC) School of Pharmacy and Lew Kontnik of Amgen are the organizers of the upcoming “Building Pharmaceutical Anti-Counterfeiting Programs” course, which will take place on Nov. 18 at USC.
PSM Board Members to Speak at NADDI’s 20th Anniversary Conference
The Partnership for Safe Medicines is proud to have Dr. James Class and board member Marv D. Shepherd speaking at the National Association of Drug Diversion Investigators (NADDI) 20th Anniversary Conference, November 17-20 in Annapolis, Md. The NADDI is a non-profit organization that works with law enforcement, […]
PSAs Warn Cambodians of Counterfeit Drug Dangers
Earlier this month, a public health campaign was launched in Cambodia to help raise awareness and combat the rising threat of counterfeit drugs throughout Southeast Asia. The campaign, launched by the U.S. Agency for International Development (USAID) and the United States Pharmacopeia (USP) Convention with the support of Cambodian authorities, includes a nationally broadcasted public service announcement (PSA) series titled “Pharmacide.”
USC Spotlight on Counterfeit Drugs and Devices
On November 18, 2009, the University of Southern California (USC) will offer a one-day course called “Building Pharmaceutical Anti-Counterfeiting Programs.” The course will be taught by experts from the field and will examine the nature of the criminal challenge, government and industry roles and responsibilities […]
NBC Nightly News story about counterfeit swine flu vaccine
Visit msnbc.com for Breaking News, World News, and News about the Economy
TIME Article on Counterfeit Drugs Trade
Read the TIMES article. Washington-based agency the Pharmaceutical Security Institute, run by Partnership for Safe Medicines board member Thomas Kubic, was created to address the problem of major pharmaceutical companies losing billions every year to counterfeit drug trafficking around the world. Now a group of […]
FDA Warns of Online H1N1 Influenza Virus Drug Product Purchases
FDA is alerting you to a use extreme caution when purchasing any medication over the Internet claiming to prevent or treat H1N1 influenza virus. Several orders of the H1N1 vaccine Tamiflu (oseltamivir) purchased from online pharmacies were found to be a health threat to consumers.
The new “Spamalot” – Spam Solicitations for Counterfeit Drugs
On October 13, a USA Today article featured a report released from the antivirus company McAfee. They found that 70 percent of spam in September was from websites advertizing “Canadian pharmaceuticals.” Further, the only thing that made it “Canadian” was the word Canadian and the maple leaves on the spammers’ web page. The increase in counterfeit drug spam may be due to the rising fears surrounding H1N1 flu, as well as the intensity around the topic of healthcare costs.
Cambodia Campaigns Against Counterfeit Medicines With Aid from USP Drug Quality and Information Program
USAID and DQI Release Public Service Announcements in Regional Initiative To Increase Public Awareness The U.S. Pharmacopeia Drug Quality and Information Program (DQI) announces the official launch of the “Pharmacide” public service announcement (PSA) campaign against counterfeit medicines in Cambodia. Coinciding with this launch, the […]
Cambodia: Fighting counterfeit medicines with TV spots and Minilabs
The US Agency for International Development (USAID) and United States Pharmacopeial Convention (USP) launched a series of public service announcements on counterfeit medicines in Phnom Penh last week. First broadcast on national television in Cambodia subsequent translations into other languages will help also to spread […]